{
  "pmid": "19074054",
  "uid": "19074054",
  "title": "What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Rosovsky",
      "fore_name": "Rachel P",
      "initials": "RP",
      "name": "Rachel P Rosovsky",
      "affiliations": [
        "Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA."
      ]
    },
    {
      "last_name": "Crowther",
      "fore_name": "Mark A",
      "initials": "MA",
      "name": "Mark A Crowther",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Hematology. American Society of Hematology. Education Program",
    "iso_abbreviation": "Hematology Am Soc Hematol Educ Program",
    "issn": "1520-4391",
    "issn_type": "Print",
    "pub_year": "2008"
  },
  "start_page": "36",
  "end_page": "38",
  "pages": "36-8",
  "language": "eng",
  "publication_types": [
    "Case Reports",
    "Journal Article"
  ],
  "keywords": [
    "Anticoagulants",
    "Factor VIIa",
    "Heart Valve Prosthesis Implantation",
    "Humans",
    "Male",
    "Middle Aged",
    "Mitral Valve",
    "Recombinant Proteins",
    "Review Literature as Topic",
    "Safety",
    "Shock",
    "Warfarin"
  ],
  "article_ids": {
    "pubmed": "19074054",
    "doi": "10.1182/asheducation-2008.1.36",
    "pii": "2008/1/36"
  },
  "doi": "10.1182/asheducation-2008.1.36",
  "dates": {
    "completed": "2009-07-28",
    "revised": "2016-11-24"
  },
  "chemicals": [
    "Anticoagulants",
    "Recombinant Proteins",
    "Warfarin",
    "recombinant FVIIa",
    "Factor VIIa"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:16:31.836892",
    "pmid": "19074054"
  }
}